These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 27395443)

  • 41. APOE E4 Carriers show prospective memory enhancement under nicotine, and evidence for specialisation within medial BA10.
    Evans S; Gray MA; Dowell NG; Tabet N; Tofts PS; King SL; Rusted JM
    Neuropsychopharmacology; 2013 Mar; 38(4):655-63. PubMed ID: 23232444
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Apolipoprotein E epsilon4 allele differentiates the clinical response to donepezil in Alzheimer's disease.
    Bizzarro A; Marra C; Acciarri A; Valenza A; Tiziano FD; Brahe C; Masullo C
    Dement Geriatr Cogn Disord; 2005; 20(4):254-61. PubMed ID: 16103669
    [TBL] [Abstract][Full Text] [Related]  

  • 43. The Combined Effect of APOE and BDNF Val66Met Polymorphisms on Spatial Navigation in Older Adults.
    Laczó J; Cechova K; Parizkova M; Lerch O; Andel R; Matoska V; Kaplan V; Matuskova V; Nedelska Z; Vyhnalek M; Hort J
    J Alzheimers Dis; 2020; 78(4):1473-1492. PubMed ID: 33325388
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Association Between the APOEɛ2/ɛ4 Genotype and Alzheimer's Disease and Mild Cognitive Impairment Among African Americans.
    Ren D; Lopez OL; Lingler JH; Conley Y
    J Alzheimers Dis; 2021; 81(3):943-948. PubMed ID: 33935088
    [TBL] [Abstract][Full Text] [Related]  

  • 45. PICALM Variation Moderates the Relationships of APOE ɛ4 with Alzheimer's Disease Cerebrospinal Biomarkers and Memory Function Among Non-Demented Population.
    Liu YB; Wang XJ; Tan L; Tan CC; Xu W;
    J Alzheimers Dis; 2023; 96(4):1651-1661. PubMed ID: 38007652
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Influence of apolipoprotein E varepsilon4 on rates of cognitive and functional decline in mild cognitive impairment.
    Whitehair DC; Sherzai A; Emond J; Raman R; Aisen PS; Petersen RC; Fleisher AS;
    Alzheimers Dement; 2010 Sep; 6(5):412-9. PubMed ID: 20813342
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Visual Memory Deficits in Middle-Aged APOEɛ4 Homozygotes Detected Using Unsupervised Cognitive Assessments.
    Lim YY; Pase MP; Buckley RF; Yassi N; Bransby L; Fowler C; Laws SM; Masters CL; Maruff P
    J Alzheimers Dis; 2021; 79(4):1563-1573. PubMed ID: 33492293
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Apolipoprotein E ɛ4, Cognitive Function, and Pain Experience in Down Syndrome: A Pilot Study.
    de Knegt NC; Schuengel C; Evenhuis HM; Lobbezoo F; Scherder EJ
    Arch Clin Neuropsychol; 2016 Aug; 31(5):389-400. PubMed ID: 27193365
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Disrupted functional and structural networks in cognitively normal elderly subjects with the APOE ɛ4 allele.
    Chen Y; Chen K; Zhang J; Li X; Shu N; Wang J; Zhang Z; Reiman EM
    Neuropsychopharmacology; 2015 Mar; 40(5):1181-91. PubMed ID: 25403724
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Quantitative electroencephalography (qEEG), apolipoprotein A-I (APOA-I), and apolipoprotein epsilon 4 (APOE ɛ4) alleles for the diagnosis of mild cognitive impairment and Alzheimer's disease.
    Niu X; Wang Y; Zhang X; Wang Y; Shao W; Chen L; Yang Z; Peng D
    Neurol Sci; 2024 Feb; 45(2):547-556. PubMed ID: 37673807
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Effects of Apolipoprotein E ɛ4 and Risk Factors on Domains of Cognition in Mild Cognitive Impairment and Dementia.
    Han SH; Noh DH; Jo EJ; Kam KY
    J Alzheimers Dis; 2022; 87(3):1181-1188. PubMed ID: 35466935
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Female APOE ɛ4 Carriers with Slow Rates of Biological Aging Have Better Memory Performances Compared to Female ɛ4 Carriers with Accelerated Aging.
    O'Shea DM; Galvin JE
    J Alzheimers Dis; 2023; 92(4):1269-1282. PubMed ID: 36872781
    [TBL] [Abstract][Full Text] [Related]  

  • 53. The APOE ɛ4 allele modulates brain white matter integrity in healthy adults.
    Heise V; Filippini N; Ebmeier KP; Mackay CE
    Mol Psychiatry; 2011 Sep; 16(9):908-16. PubMed ID: 20820167
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Longitudinal brain imaging in preclinical Alzheimer disease: impact of APOE ε4 genotype.
    Mishra S; Blazey TM; Holtzman DM; Cruchaga C; Su Y; Morris JC; Benzinger TLS; Gordon BA
    Brain; 2018 Jun; 141(6):1828-1839. PubMed ID: 29672664
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Higher prevalence of cerebral white matter hyperintensities in homozygous APOE-ɛ4 allele carriers aged 45-75: Results from the ALFA study.
    Rojas S; Brugulat-Serrat A; Bargalló N; Minguillón C; Tucholka A; Falcon C; Carvalho A; Morán S; Esteller M; Gramunt N; Fauria K; Camí J; Molinuevo JL; Gispert JD
    J Cereb Blood Flow Metab; 2018 Feb; 38(2):250-261. PubMed ID: 28492093
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Differential Associations of Apolipoprotein E ε4 Genotype With Attentional Abilities Across the Life Span of Individuals With Down Syndrome.
    D'Souza H; Mason L; Mok KY; Startin CM; Hamburg S; Hithersay R; Baksh RA; Hardy J; Strydom A; Thomas MSC;
    JAMA Netw Open; 2020 Sep; 3(9):e2018221. PubMed ID: 32986108
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Association between enzymatic and non-enzymatic antioxidant defense mechanism with apolipoprotein E genotypes in Alzheimer disease.
    Kharrazi H; Vaisi-Raygani A; Rahimi Z; Tavilani H; Aminian M; Pourmotabbed T
    Clin Biochem; 2008 Aug; 41(12):932-6. PubMed ID: 18505684
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Aβ amyloid, cognition, and APOE genotype in healthy older adults.
    Lim YY; Ellis KA; Ames D; Darby D; Harrington K; Martins RN; Masters CL; Rowe C; Savage G; Szoeke C; Villemagne VL; Maruff P;
    Alzheimers Dement; 2013 Sep; 9(5):538-45. PubMed ID: 23159043
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Apolipoprotein E ɛ2/ɛ3/ɛ4 variant in association with obstructive sleep apnoea and lipid profile: A meta-analysis.
    Lu Z; Wu X; Jin X; Peng F; Lin J
    J Int Med Res; 2016 Feb; 44(1):3-14. PubMed ID: 26740500
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Body Mass Index Decrease Has a Distinct Association with Alzheimer's Disease Pathophysiology in APOE ɛ4 Carriers and Non-Carriers.
    Li A; Du J; Cai Y; Chen X; Sun K; Guo T;
    J Alzheimers Dis; 2023; 96(2):643-655. PubMed ID: 37840490
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.